| Date | Title | Description | Source |
| 16.04.2024 | ADC Therapeutics Accelerates R&D with Genedata Biologics | Digitalizing Biopharma R&D: The Genedata Biopharma Platform is the #1 enterprise software system... | prweb.com/... |
| 13.03.2024 | ADC Therapeutics Reports Fourth Quarter and Full Year 2023 F... | - | globenewsw... |
| 06.03.2024 | ADC Therapeutics nimmt am Guggenheim 5th Annual Healthy Alti... | - | globenewsw... |
| 06.03.2024 | ADC Therapeutics to Participate in the Guggenheim 5th Annual... | - | globenewsw... |
| 06.03.2024 | ADC Therapeutics gibt die Annahme von Abstracts zur Präsenta... | - | globenewsw... |
| 06.03.2024 | ADC Therapeutics veranstaltet am 13. März 2024 eine Telefonk... | - | globenewsw... |
| 05.03.2024 | ADC Therapeutics Announces Abstracts Accepted for Presentati... | - | globenewsw... |
| 20.11.2023 | Sobi to present new data at ASH 2023 Annual Meeting | Sobi to present new data at ASH 2023 Annual Meeting
Mon, Nov 20, 2023 08:00 CET Report this content
... | news.cisio... |
| 02.06.2023 | Sobi to present new data at the 2023 EHA congress | Sobi to present new data at the 2023 EHA congress
Fri, Jun 02, 2023 09:00 CET Report this content
So... | news.cisio... |
| 28.12.2022 | ADC Therapeutics gains EU clearance for Zynlonta | | startuptic... |
| 21.12.2022 | Zynlonta® (loncastuximab tesirine) approved in the EU for th... | Zynlonta® (loncastuximab tesirine) approved in the EU for the treatment of relapsed or refractory di... | news.cisio... |
| 16.09.2022 | Loncastuximab tesirine receives positive CHMP opinion for th... | Loncastuximab tesirine receives positive CHMP opinion for the treatment of relapsed or refractory di... | news.cisio... |
| 09.05.2022 | Seagen CEO Clay Siegall was placed on leave after an April... | Around a year ago, Ameet Mallik left his post at Novartis, where he had spent the last 16 years, to ... | endpts.com... |
| 19.01.2022 | ADC Therapeutics Announces Exclusive License with Mitsubishi... | LAUSANNE, Switzerland - ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company i... | marketscre... |
| 19.01.2022 | ADC Therapeutics secures $30 million in new partnership deal | | startuptic... |
| 04.11.2021 | ADC Therapeutics Announces Abstracts to be Presented at the ... | ADC Therapeutics Announces Abstracts to be Presented at the 63rd ASH Annual Meeting
Several presenta... | marketscre... |
| 27.08.2021 | ADC Therapeutics signs financial agreement for up to $325 Mi... | | startuptic... |
| 26.08.2021 | ADC Therapeutics sells off royalty share for lead anti... | ADC Therapeutics will receive $225 million in cash and an additional $100 million in near-t... | endpts.com... |
| 09.06.2021 | ADC THERAPEUTICS SA
ADC Therapeutics : Announces Presentati... | ADC Therapeutics Announces Presentations at the 16th Annual International Conference on Malignant Ly... | marketscre... |
| 06.05.2021 | ADC Therapeutics : Reports First Quarter 2021 Financial Resu... | ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company leading the development o... | marketscre... |
| 27.04.2021 | ADC Therapeutics obtains its first FDA approval for its Lymp... | Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma in the United St... | startuptic... |
| 27.04.2021 | ADC Therapeutics obtains its first FDA approval for its Lymp... | | startuptic... |
| 14.12.2020 | ADC Therapeutics launches Joint Venture for the Chinese mark... | | startuptic... |
| 14.12.2020 | ADC Therapeutics launches Joint Venture for the Chinese mark... | Under the terms of the agreement, ADC Therapeutics licensed exclusive development and commercializat... | startuptic... |
| 20.11.2020 | ADC Therapeutics Announces FDA’s Acceptance of its Biologics... | LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm fo... | 4biocapita... |
| 05.07.2020 | ADC Therapeutics Completes $267M IPO | ADC Therapeutics (NYSE:ADCT), a Swiss and US late clinical-stage oncology-focused biotechnology comp... | finsmes.co... |
| 30.06.2020 | ADC THERAPEUTICS SA
ADC Therapeutics : New Ventures Portfol... | VIRGINIA BEACH, Va., June 30, 2020 /PRNewswire/ -- New Ventures Funds, a venture fund targeting inve... | marketscre... |
| 22.05.2020 | Successful IPO of ADC Therapeutics | ADC Therapeutics closed its initial public offering of 14,082,475 shares of its common shares at a p... | startuptic... |
| 22.05.2020 | Successful IPO of ADC Therapeutics | | startuptic... |
| 20.05.2020 | 4BIO Capital portfolio company ADC Therapeutics SA closes an... | LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm fo... | 4biocapita... |
| 15.05.2020 | ADC Therapeutics aims to raise $230 million in IPO | | startuptic... |
| 15.05.2020 | ADC Therapeutics aims to raise $230 million in IPO | ADC Therapeutics SA headquarted at Biopôle in Epalinges close to Lausanne is a late clinical-stage o... | startuptic... |
| 11.05.2020 | Fritz Gerber, who led Roche for 2 decades, dies; ADC Thera... | → Fritz Gerber, the 92-year-old ex-Roche CEO who steered the company to a majority stake in Ge... | endpts.com... |
| 27.04.2020 | Second attempt: ADC Therapeutics starts IPO process | ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company pioneering the d... | startuptic... |
| 27.04.2020 | Second attempt: ADC Therapeutics starts IPO process | | startuptic... |
| 13.09.2019 | ADC Therapeutics recognized with Excellence Award at Converg... | | startuptic... |
| 10.09.2019 | ADC Therapeutics to go public | | startuptic... |
| 06.08.2019 | Two Swiss scale-ups team up to fight cancer | | startuptic... |
| 10.07.2019 | ADC Therapeutics finalises a $303M series E round | | startuptic... |
| 12.06.2019 | ADC Therapeutics raises additional $76 million | | startuptic... |
| 12.06.2019 | ADC Therapeutics beefs up monster $200M round with fresh... | Days after Roche secured accelerated approval for its antibody-drug conjugate, Lausanne,... | endpts.com... |
| 07.08.2018 | ADC Therapeutics doses first patient in Phase II clinical tr... | | startuptic... |
| 24.10.2017 | Term Sheet — Tuesday, October 24 | THREE THINGS
Good morning, Term Sheet readers.
Paid Content A.I. is the answer to protecting your en... | fortune.co... |
| 23.10.2017 | ADC Therapeutics Announces Closing of $200 Million Private F... | | startuptic... |
| 23.10.2017 | ADC Therapeutics Closes $200M Financing | ADC Therapeutics (ADCT), a Lausanne, Switzerland-based oncology drug discovery and development compa... | finsmes.co... |
| 27.10.2016 | ADC Therapeutics Announces Closing of $105 Million Private F... | | startuptic... |
| 02.09.2015 | Daily funding roundup - September 2, 2015 | Tanium landed $120M; NewsCred bagged $42M; Universal Avenue secured $5M
ConnectedYard, an innovator ... | vator.tv/n... |
| 02.09.2015 | ADC Therapeutics Secures $80m Financing | | startuptic... |
| 02.09.2015 | ADC Therapeutics Raises $80M in Equity Funding | ADC Therapeutics, a Lausanne, Switzerland-based oncology drug discovery and development company that... | finsmes.co... |
| 15.10.2013 | MedImmune and Auven invest USD 40 million in ADC Therapeutic... | | startuptic... |
| - | ADC Therapeutics Reports Fourth Quarter and Year-End 2020 Fi... | LAUSANNE, Switzerland--(BUSINESS WIRE)--Mar 18, 2021--
ADC Therapeutics SA (NYSE: ADCT), a late clin... | oaoa.com/n... |
| - | ADC Therapeutics to Participate in Cowen 41st Annual Health ... | LAUSANNE, Switzerland--(BUSINESS WIRE)--Feb 25, 2021--
ADC Therapeutics SA (NYSE:ADCT), a late clini... | oaoa.com/n... |
| - | ADC Therapeutics to Host Fourth Quarter and Year-End 2020 Fi... | LAUSANNE, Switzerland--(BUSINESS WIRE)--Mar 11, 2021--
ADC Therapeutics SA (NYSE: ADCT), a late clin... | oaoa.com/n... |
